NAPROXEN SODIUM
- Product NDC
- 41226-609
- 11-digit product format
- 412260609
- Labeler code
- 41226
- Product ID
- 41226-609_c3d6166b-be1b-328a-e053-2a95a90af589
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- NAPROXEN SODIUM
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Kroger Company
- Application
- ANDA090545
- Marketing category
- ANDA
- Marketing start
- 2021-06-12
- Substance
- NAPROXEN SODIUM
- Active strength
- 220 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 9TN87S3A3C | NAPROXEN SODIUM | 26159-34-2 | NAPROXEN SODIUM |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 41226-609-05 | 41226060905 | 1 BOTTLE in 1 CARTON (41226-609-05) / 50 TABLET, COATED in 1 BOTTLE | 1 bottle | 2021-06-12 | No | No | Historical |